Neurocognitive dysfunction in hematopoietic cell transplant recipients: expert review from the late effects and Quality of Life Working Committee of the CIBMTR and complications and Quality of Life Working Party of the EBMT

[1]  M. C. Monahan,et al.  Children's Memory Scale , 2001, Definitions.

[2]  T. Handy,et al.  Effect of aerobic exercise on cancer‐associated cognitive impairment: A proof‐of‐concept RCT , 2018, Psycho-oncology.

[3]  H. Jim,et al.  The Role of Age in Neurocognitive Functioning among Adult Allogeneic Hematopoietic Cell Transplant Recipients. , 2017, Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation.

[4]  Federica Scarpina,et al.  The Stroop Color and Word Test , 2017, Front. Psychol..

[5]  S. Bhatia,et al.  Single Nucleotide Polymorphisms (SNPs) Associated with Cognitive Impairment in Patients Treated with Hematopoietic Cell Transplantation (HCT): A Longitudinal Study , 2016 .

[6]  J. Kurtzberg,et al.  Late Effects after Umbilical Cord Blood Transplantation in Very Young Children after Busulfan-Based, Myeloablative Conditioning. , 2016, Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation.

[7]  H. Heslop,et al.  T cells for viral infections after allogeneic hematopoietic stem cell transplant. , 2016, Blood.

[8]  A. Starkweather,et al.  The relationship of cognitive performance to concurrent symptoms, cancer- and cancer-treatment-related variables in women with early-stage breast cancer: a 2-year longitudinal study , 2016, Journal of Cancer Research and Clinical Oncology.

[9]  Joost Dekker,et al.  Developing a Risk Prediction Model for Long-Term Physical and Psychological Functioning after Hematopoietic Cell Transplantation. , 2016, Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation.

[10]  J. Lipton,et al.  Relationship between neurocognitive functioning and medication management ability over the first 6 months following allogeneic stem cell transplantation , 2016, Bone Marrow Transplantation.

[11]  Asim A. Shah,et al.  Neuropsychological Assessment in Neurocognitive Disorders , 2016 .

[12]  F. Zou,et al.  The genetic fingerprint of susceptibility for transplant-associated thrombotic microangiopathy. , 2015, Blood.

[13]  Matthew A. Scoggins,et al.  Computerized Cognitive Training for Amelioration of Cognitive Late Effects Among Childhood Cancer Survivors: A Randomized Controlled Trial. , 2015, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

[14]  J. Bay,et al.  Use of Eculizumab in Patients With Allogeneic Stem Cell Transplant-Associated Thrombotic Microangiopathy: A Study From the SFGM-TC , 2015, Transplantation.

[15]  M. Irwin,et al.  Inflammatory Biomarkers, Comorbidity, and Neurocognition in Women With Newly Diagnosed Breast Cancer. , 2015, Journal of the National Cancer Institute.

[16]  T. Prell,et al.  Clinical Management of Posterior Reversible Encephalopathy Syndrome after Allogeneic Hematopoietic Stem Cell Transplantation: A Case Series and Review of the Literature , 2015, Acta Haematologica.

[17]  Karl Frauendorfer,et al.  One million haemopoietic stem-cell transplants: a retrospective observational study. , 2015, The Lancet. Haematology.

[18]  K. Ness,et al.  The Childhood Cancer Survivor Study-Neurocognitive Questionnaire (CCSS-NCQ) revised: item response analysis and concurrent validity. , 2015, Neuropsychology.

[19]  B. Lange,et al.  Developing interventions for cancer-related cognitive dysfunction in childhood cancer survivors. , 2014, Journal of the National Cancer Institute.

[20]  A. King,et al.  Survivorship: cognitive function, version 1.2014. , 2014, Journal of the National Comprehensive Cancer Network : JNCCN.

[21]  D. Berry,et al.  Risk factors for depression in patients undergoing hematopoietic cell transplantation. , 2014, Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation.

[22]  S. Donaldson,et al.  Survival and neurocognitive outcomes after cranial or craniospinal irradiation plus total-body irradiation before stem cell transplantation in pediatric leukemia patients with central nervous system involvement. , 2014, International journal of radiation oncology, biology, physics.

[23]  M. Arbabi,et al.  Assessing cognition, depression and anxiety in hospitalized patients during pre and post-Bone Marrow Transplantation , 2014, Iranian journal of psychiatry.

[24]  M. Bishop,et al.  Symptom distress predicts long-term health and well-being in allogeneic stem cell transplantation survivors. , 2014, Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation.

[25]  A. King,et al.  Survivorship: cognitive function, version 1.2014. , 2014, Journal of the National Comprehensive Cancer Network : JNCCN.

[26]  C. Cleeland,et al.  Acute cognitive impairment in patients with multiple myeloma undergoing autologous hematopoietic stem cell transplant , 2013, Cancer.

[27]  K. Kuntz,et al.  Prevalence of hematopoietic cell transplant survivors in the United States. , 2013, Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation.

[28]  A. Mehnert,et al.  Cognitive functioning in allogeneic hematopoietic stem cell transplantation recipients and its medical correlates: a prospective multicenter study , 2013, Psycho-oncology.

[29]  L. Westlye,et al.  Reduced neuroanatomic volumes in long-term survivors of childhood acute lymphoblastic leukemia. , 2013, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

[30]  S. Fosså,et al.  Factors associated with poor quality of life in survivors of childhood acute lymphoblastic leukemia and lymphoma , 2013, Pediatric blood & cancer.

[31]  H. Jim,et al.  A systematic review and meta-analysis of changes in cognitive functioning in adults undergoing hematopoietic cell transplantation , 2013, Bone Marrow Transplantation.

[32]  R. Giller,et al.  Late effects of total body irradiation and hematopoietic stem cell transplant in children under 3 years of age , 2013, Pediatric blood & cancer.

[33]  G. Kaspers,et al.  Sleep, fatigue, depression, and quality of life in survivors of childhood acute lymphoblastic leukemia , 2013, Pediatric blood & cancer.

[34]  K. Peck,et al.  A prospective evaluation of changes in brain structure and cognitive functions in adult stem cell transplant recipients , 2013, Brain Imaging and Behavior.

[35]  A. Ardila,et al.  Executive dysfunction , 2013 .

[36]  A. Hutchinson,et al.  Objective and subjective cognitive impairment following chemotherapy for cancer: a systematic review. , 2012, Cancer treatment reviews.

[37]  Nancy Bayley,et al.  BAYLEY SCALES OF INFANT AND TODDLER DEVELOPMENT, THIRD EDITION (BAYLEY-III) , 2014 .

[38]  C. Cleeland,et al.  Symptoms and quality of life in diverse patients undergoing hematopoietic stem cell transplantation. , 2012, Journal of pain and symptom management.

[39]  H. Jim,et al.  Clinical predictors of cognitive function in adults treated with hematopoietic cell transplantation , 2012, Cancer.

[40]  G. Reifenberger,et al.  Temozolomide chemotherapy alone versus radiotherapy alone for malignant astrocytoma in the elderly: the NOA-08 randomised, phase 3 trial. , 2012, The Lancet. Oncology.

[41]  N. Grulke,et al.  Quality of life in patients before and after haematopoietic stem cell transplantation measured with the European Organization for Research and Treatment of Cancer (EORTC) Quality of Life Core Questionnaire QLQ-C30 , 2012, Bone Marrow Transplantation.

[42]  E. Vakil.  Neuropsychological assessment: Principles, rationale, and challenges , 2012, Journal of clinical and experimental neuropsychology.

[43]  S. Dikmen,et al.  Prospective neurocognitive function over 5 years after allogeneic hematopoietic cell transplantation for cancer survivors compared with matched controls at 5 years. , 2011, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

[44]  H. Conklin,et al.  Parent and teacher ratings of attention during a year-long methylphenidate trial in children treated for cancer. , 2011, Journal of pediatric psychology.

[45]  K. Hardy,et al.  Computerized Cognitive Training in Survivors of Childhood Cancer , 2011, Journal of pediatric oncology nursing : official journal of the Association of Pediatric Oncology Nurses.

[46]  John DeLuca,et al.  Encyclopedia of Clinical Neuropsychology , 2013 .

[47]  D. Dinges,et al.  A meta-analysis of the impact of short-term sleep deprivation on cognitive variables. , 2010, Psychological bulletin.

[48]  P. Schofield,et al.  The relationship between unmet needs and distress amongst young people with cancer , 2010, Supportive Care in Cancer.

[49]  K. Krull,et al.  Oxidative stress and executive function in children receiving chemotherapy for acute lymphoblastic leukemia , 2009, Pediatric blood & cancer.

[50]  Sunita K. Patel,et al.  Cognitive and Problem Solving Training in Children with Cancer: A Pilot Project , 2009, Journal of pediatric hematology/oncology.

[51]  K. Wesnes,et al.  The effect of modafinil on cognitive function in breast cancer survivors , 2009, Cancer.

[52]  H. Buchtel,et al.  Dynamic Contrast-Enhanced Magnetic Resonance Imaging As a Biomarker for Prediction of Radiation-Induced Neurocognitive Dysfunction , 2009, Clinical Cancer Research.

[53]  T. Cole,et al.  Cognitive and behavioral abnormalities in children after hematopoietic stem cell transplantation for severe congenital immunodeficiencies. , 2008, Blood.

[54]  A. Smedler,et al.  Neuropsychological outcome in very young hematopoietic SCT recipients in relation to pretransplant conditioning , 2008, Bone Marrow Transplantation.

[55]  B. Moore,et al.  Preventing Neurocognitive Late Effects in Childhood Cancer Survivors , 2008, Journal of child neurology.

[56]  M. Westerveld,et al.  State of Multicultural Neuropsychological Assessment in Children: Current Research Issues , 2008, Neuropsychology Review.

[57]  D. Kohn,et al.  Long-Term Neurocognitive Function of Pediatric Patients with Severe Combined Immune Deficiency (SCID): Pre- and Post-Hematopoietic Stem Cell Transplant (HSCT) , 2008, Journal of Clinical Immunology.

[58]  J. Deijen,et al.  The usefulness of growth hormone treatment for psychological status in young adult survivors of childhood leukaemia: an open-label study , 2008, BMC pediatrics.

[59]  R. Mulhern,et al.  A multicenter, randomized clinical trial of a cognitive remediation program for childhood survivors of a pediatric malignancy. , 2008, Journal of consulting and clinical psychology.

[60]  K. Weinberg,et al.  Progressive Declines in Neurocognitive Function Among Survivors of Hematopoietic Stem Cell Transplantation for Pediatric Hematologic Malignancies , 2008, Journal of pediatric hematology/oncology.

[61]  S. Rai,et al.  Cognitive and academic consequences of stem-cell transplantation in children. , 2008, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

[62]  E. Atenafu,et al.  Cognitive, educational, psychosocial adjustment and quality of life of children who survive hematopoietic SCT and their siblings , 2008, Bone Marrow Transplantation.

[63]  Kerstin Albertsson-Wikland,et al.  Continuous growth reference from 24th week of gestation to 24 months by gender , 2008, BMC pediatrics.

[64]  M. Barrera,et al.  Factors related to changes in cognitive, educational and visual motor integration in children who undergo hematopoietic stem cell transplant. , 2007, Journal of pediatric psychology.

[65]  J. Steinberger,et al.  Long‐term follow‐up of children who underwent hematopoeitic cell transplant (HCT) for AML or ALL at less than 3 years of age , 2007, Pediatric blood & cancer.

[66]  A. Nademanee,et al.  Late mortality after allogeneic hematopoietic cell transplantation and functional status of long-term survivors: report from the Bone Marrow Transplant Survivor Study. , 2007, Blood.

[67]  J. Lipton,et al.  Central nervous system complications after allogeneic hematopoietic stem cell transplantation: incidence, manifestations, and clinical significance. , 2007, Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation.

[68]  P. Jacobsen,et al.  Changes in cognitive functioning in the year after hematopoietic stem cell transplantation , 2007, Cancer.

[69]  Charles L Truwit,et al.  Posterior reversible encephalopathy syndrome: incidence of atypical regions of involvement and imaging findings. , 2007, AJR. American journal of roentgenology.

[70]  Deborah A. Yurgelun-Todd,et al.  Neuropsychological Consequences of Opiate Use , 2007, Neuropsychology Review.

[71]  Craig A. Albers,et al.  Test Review: Bayley, N. (2006). Bayley Scales of Infant and Toddler Development– Third Edition. San Antonio, TX: Harcourt Assessment , 2007 .

[72]  A. Zander,et al.  Cognitive function in the acute course of allogeneic hematopoietic stem cell transplantation for hematological malignancies , 2007, Bone Marrow Transplantation.

[73]  E. Lis,et al.  Posterior reversible encephalopathy syndrome due to sirolimus , 2007, Bone Marrow Transplantation.

[74]  T. Shamsi,et al.  Psychiatric disorders in bone marrow transplant patients. , 2007, Journal of the College of Physicians and Surgeons--Pakistan : JCPSP.

[75]  M. Wozniak,et al.  VIRAL INFECTION AND COGNITIVE DECLINE , 2007, Journal of the American Geriatrics Society.

[76]  Jonathan J. Evans,et al.  A review of screening tests for cognitive impairment , 2006, Journal of Neurology, Neurosurgery & Psychiatry.

[77]  Jeff A Sloan,et al.  Rising importance of patient-reported outcomes. , 2006, The Lancet. Oncology.

[78]  M. J. van den Bent,et al.  Neurocognitive Functions and Quality of Life in Haematological Patients Receiving Haematopoietic Stem Cell Grafts: A One-Year Follow-Up Pilot Study , 2006, Journal of clinical and experimental neuropsychology.

[79]  R. Schwartz,et al.  MR imaging of human herpesvirus-6-associated encephalitis in 4 patients with anterograde amnesia after allogeneic hematopoietic stem-cell transplantation. , 2006, AJNR. American journal of neuroradiology.

[80]  E. Shaw,et al.  Phase II study of donepezil in irradiated brain tumor patients: effect on cognitive function, mood, and quality of life. , 2006, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

[81]  J. Wingard,et al.  Recommended screening and preventive practices for long-term survivors after hematopoietic cell transplantation: joint recommendations of the European Group for Blood and Marrow Transplantation, the Center for International Blood and Marrow Transplant Research, and the American Society of Blood and , 2006, Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation.

[82]  P. Jacobsen,et al.  Characteristics and correlates of cognitive functioning following bone marrow transplantation , 2005, Bone Marrow Transplantation.

[83]  J. Lucas,et al.  Disorders of memory. , 2005, The Psychiatric clinics of North America.

[84]  P. Mazzone,et al.  S100beta as a predictor of brain metastases: brain versus cerebrovascular damage. , 2005, Cancer.

[85]  A. Nademanee,et al.  Late mortality in survivors of autologous hematopoietic-cell transplantation: report from the Bone Marrow Transplant Survivor Study. , 2005, Blood.

[86]  A. Twijnstra,et al.  Neuron-specific enolase as a marker of brain metastasis in patients with small-cell lung carcinoma , 2005, Journal of Neuro-Oncology.

[87]  S. Dikmen,et al.  Neuropsychologic changes from before transplantation to 1 year in patients receiving myeloablative allogeneic hematopoietic cell transplant. , 2004, Blood.

[88]  T. Tombaugh.  Trail Making Test A and B: normative data stratified by age and education. , 2004, Archives of clinical neuropsychology : the official journal of the National Academy of Neuropsychologists.

[89]  M. Besser,et al.  The effects of transdermal fentanyl on driving, cognitive performance, and balance in patients with chronic nonmalignant pain conditions. , 2004, Pain medicine.

[90]  A. Angold,et al.  Continuous Performance Test Performance in a Normative Epidemiological Sample , 2003, Journal of abnormal child psychology.

[91]  A. Kanner,et al.  Serum S100β , 2003, Cancer.

[92]  G. Dellatolas,et al.  Neuropsychological outcome in long-term survivors of a childhood extracranial solid tumor who have undergone autologous bone marrow transplantation , 2003, Bone Marrow Transplantation.

[93]  A. Straube,et al.  Prospective evaluation of neurological complications after allogeneic bone marrow transplantation , 2003, Neurology.

[94]  T. Neumann-Haefelin,et al.  S100B as a surrogate marker for successful clot lysis in hyperacute middle cerebral artery occlusion , 2003, Journal of neurology, neurosurgery, and psychiatry.

[95]  T. Yoshikawa.  Human herpesvirus‐6 and ‐7 infections in transplantation , 2003, Pediatric transplantation.

[96]  D. Margolis,et al.  Cognitive and psychosocial functioning of pediatric hematopoietic stem cell transplant patients: A prospective longitudinal study , 2002, Bone Marrow Transplantation.

[97]  M. Grootenhuis,et al.  Quality of life in young adult survivors of childhood cancer , 2002, Supportive Care in Cancer.

[98]  M. J. van den Bent,et al.  Cognitive functioning and quality of life in long‐term adult survivors of bone marrow transplantation , 2002, Cancer.

[99]  Martin Müller,et al.  Mild cognitive impairment after viral meningitis in adults , 2002, Journal of Neurology.

[100]  Á. Chamorro,et al.  Inflammation-Mediated Damage in Progressing Lacunar Infarctions: A Potential Therapeutic Target , 2002, Stroke.

[101]  A. Kazak,et al.  Cognitive, Behavioral, and Social Outcome in Survivors of Childhood Stem Cell Transplantation , 2002, Journal of pediatric hematology/oncology.

[102]  F. D. Armstrong.  Acute and long-term neurodevelopmental outcomes in children following bone marrow transplantation. , 2001, Frontiers in bioscience : a journal and virtual library.

[103]  J. Serena,et al.  Neurological Deterioration in Acute Lacunar Infarctions: The Role of Excitatory and Inhibitory Neurotransmitters , 2001, Stroke.

[104]  F. André,et al.  Brain metastases at the time of presentation of non-small cell lung cancer: a multi-centric AERIO analysis of prognostic factors , 2001, British Journal of Cancer.

[105]  W E Reddick,et al.  Immediate neurocognitive effects of methylphenidate on learning-impaired survivors of childhood cancer. , 2001, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

[106]  R. Cannan,et al.  Serum proinflammatory cytokine response in patients with advanced liver tumors following selective internal radiation therapy (SIRT) with (90)Yttrium microspheres. , 2001, International journal of radiation oncology, biology, physics.

[107]  A. Saykin,et al.  Cognitive Effects of Standard-Dose Chemotherapy in Patients with Cancer , 2001, Cancer investigation.

[108]  Á. Chamorro,et al.  Proinflammatory Cytokines and Early Neurological Worsening in Ischemic Stroke , 2000, Stroke.

[109]  G. Gioia,et al.  TEST REVIEW Behavior Rating Inventory of Executive Function , 2000 .

[110]  G. Gioia,et al.  Behavior Rating Inventory for Executive Function , 2000 .

[111]  G. Gioia,et al.  TEST REVIEW Behavior Rating Inventory of Executive Function , 2000 .

[112]  R. Mulhern,et al.  Cognitive and academic functioning in survivors of pediatric bone marrow transplantation. , 2000, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

[113]  C. Meyers.  Neurocognitive dysfunction in cancer patients. , 2000, Oncology.

[114]  C. Berking,et al.  S-100 protein in peripheral blood: a marker for melanoma metastases: a prospective 2-center study of 570 patients with melanoma. , 1999, Journal of the American Academy of Dermatology.

[115]  N. Denburg,et al.  Adult norms for the Rey-Osterrieth Complex Figure Test and for supplemental recognition and matching trials from the Extended Complex Figure Test. , 1999, The Clinical neuropsychologist.

[116]  P. Cagnoni,et al.  Optic disc and retinal microvasculopathy after high-dose chemotherapy and autologous hematopoietic progenitor cell support , 1999, Bone Marrow Transplantation.

[117]  C. Randolph,et al.  The Repeatable Battery for the Assessment of Neuropsychological Status (RBANS): preliminary clinical validity. , 1998, Journal of clinical and experimental neuropsychology.

[118]  S. Rodenhuis,et al.  Impairment of cognitive function in women receiving adjuvant treatment for high-risk breast cancer: high-dose versus standard-dose chemotherapy. , 1998, Journal of the National Cancer Institute.

[119]  Ralph H. B. Benedict,et al.  Hopkins Verbal Learning Test—Revised: Normative data and analysis of inter-form and test–retest reliability. , 1998 .

[120]  J. Kramer,et al.  Cognitive and adaptive behavior 1 and 3 years following bone marrow transplantation , 1997, Bone Marrow Transplantation.

[121]  A. Dávalos,et al.  Progression of ischaemic stroke and excitotoxic aminoacids , 1997, The Lancet.

[122]  Cool Va.  Long-term neuropsychological risks in pediatric bone marrow transplant: what do we know? , 1996 .

[123]  D. Drachman,et al.  The Cognitive Assessment Screening Test (CAST) for Dementia , 1996, Journal of geriatric psychiatry and neurology.

[124]  E. Masliah,et al.  Viral persistence in neurons alters synaptic plasticity and cognitive functions without destruction of brain cells. , 1996, Virology.

[125]  J. Kramer,et al.  Toxicities of total-body irradiation for pediatric bone marrow transplantation. , 1996, International journal of radiation oncology, biology, physics.

[126]  V. Cool.  Long-term neuropsychological risks in pediatric bone marrow transplant: what do we know? , 1996, Bone marrow transplantation.

[127]  E. Arnoldus,et al.  A reversible posterior leukoencephalopathy syndrome. , 1996, The New England journal of medicine.

[128]  H. Withers,et al.  Induction of acute phase gene expression by brain irradiation. , 1995, International journal of radiation oncology, biology, physics.

[129]  P. Barnes,et al.  Cyclosporine neurotoxicity and its relationship to hypertensive encephalopathy: CT and MR findings in 16 cases. , 1995, AJR. American journal of roentgenology.

[130]  R. Mulhern,et al.  Psychological effects of bone marrow transplantation on children and adolescents: preliminary report of a longitudinal study. , 1995, Bone marrow transplantation.

[131]  A. Smedler,et al.  Neuropsychological deficits in very young bone marrow transplant recipients , 1995, Acta paediatrica.

[132]  A. Smedler,et al.  Total body irradiation: a neuropsychological risk factor in pediatric bone marrow transplant recipients , 1995, Acta paediatrica.

[133]  P. Rabbitt,et al.  Cambridge Neuropsychological Test Automated Battery (CANTAB): a factor analytic study of a large sample of normal elderly volunteers. , 1994, Dementia.

[134]  R. Champlin,et al.  Evaluation of the neurobehavioral functioning of patients before, during, and after bone marrow transplantation. , 1994, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

[135]  E. Teng,et al.  The Cognitive Abilities Screening Instrument (CASI): A Practical Test for Cross-Cultural Epidemiological Studies of Dementia , 1994, International Psychogeriatrics.

[136]  W. Baile,et al.  Hallucinations and ifosfamide‐induced neurotoxicity , 1994, Cancer.

[137]  R M Ruff,et al.  Gender- and Age-Specific Changes in Motor Speed and Eye-Hand Coordination in Adults: Normative Values for the Finger Tapping and Grooved Pegboard Tests , 1993, Perceptual and motor skills.

[138]  J. Kramer,et al.  A prospective study of cognitive functioning following low-dose cranial radiation for bone marrow transplantation. , 1992, Pediatrics.

[139]  F. Appelbaum,et al.  Allogeneic marrow transplantation in patients with chronic myeloid leukemia in the chronic phase: a randomized trial of two irradiation regimens. , 1991, Blood.

[140]  R. Weiss,et al.  Cytarabine and neurologic toxicity. , 1991, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

[141]  F. Appelbaum,et al.  Allogeneic marrow transplantation in patients with acute myeloid leukemia in first remission: a randomized trial of two irradiation regimens. , 1990, Blood.

[142]  R. Dodge,et al.  Ifosfamide neurotoxicity is related to previous cisplatin treatment for pediatric solid tumors. , 1990, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

[143]  A. Smith.  Viral infections, immune responses and cognitive performance. , 1990, The International journal of neuroscience.

[144]  O. Burghuber,et al.  Clinical biochemistry of neuron specific enolase. , 1989, Clinica chimica acta; international journal of clinical chemistry.

[145]  R. Mercier,et al.  Acute neurologic dysfunction after high‐dose etoposide therapy for malignant glioma , 1988, Cancer.

[146]  E. Kaplan,et al.  Integrating clinical assessment with cognitive neuroscience: construct validation of the California Verbal Learning Test. , 1988, Journal of consulting and clinical psychology.

[147]  H. Chui,et al.  The Modified Mini-Mental State (3MS) examination. , 1987, The Journal of clinical psychiatry.

[148]  J. Fay,et al.  Encephalomyelopathy following high‐dose BCNU therapy , 1981 .

[149]  David Wechsler,et al.  Wechsler Intelligence Scale for Children; manual. , 1949 .